Aller au contenu principal
Accès ouvert déclaré 2025 article

Identification of gestational diabetes mellitus in European electronic healthcare databases: insights from the ConcePTION project

1Citations signalées, ce qui n’est pas une note de qualité
13Institutions déclarées
10Pays d’affiliation déclarés

Rattachement africain : dk, ch, no, nl, us, gb, fi, it, es, fr. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Objective To develop and compare algorithms for identifying gestational diabetes mellitus (GDM) across European electronic healthcare databases and evaluate their impact on the estimated prevalence. Design Multi-national cohort study using routinely collected electronic healthcare data Setting National and regional databases in five European countries (Norway, Finland, Italy, Spain and France), in primary and/or secondary care. Participants Pregnancy cohorts resulting in stillbirths or live births between 2009 and 2020, comprising 602 897 pregnancies in Norway, 507 904 in Finland, 374 009 in Italy, 193 495 in Spain and 116 762 in France. Primary and secondary outcomes The primary outcome was the prevalence of GDM identified using six algorithms: (1) Only diagnosis; (2) Diagnosis or prescription; (3) Two diagnoses or prescriptions ( 2DxRx ); (4) Diagnosis including unspecified diabetes in pregnancy or prescription ( DxRx broad ); (5) Diagnosis excluding pre-existing diabetes in pregnancy or prescription; (6) Registration of GDM in a birth registry ( BR ). Results The strictest algorithm ( 2DxRx ) resulted in the lowest GDM prevalence, while the broadest ( DxRx broad ) resulted in the highest, except in France where it was BR . In the Nordic countries, GDM prevalence varied only slightly by algorithm; greater variations were observed in other countries. The prevalence ranged from 3.5% (95% CI: 3.5% to 3.5%) to 4.6% (95% CI: 4.5% to 4.7%) in Norway; 12.1% (95% CI: 12.0% to 12.2%) to 15.8% (95% CI: 15.7% to 15.9%) in Finland, where prevalence was much higher than elsewhere. The prevalence ranged from 1.3% (95% CI: 1.3% to 1.3%) to 5.4% (95% CI: 5.3% to 5.5%) in Italy; 1.6% (95% CI: 1.5% to 1.7%) to 6.2% (95% CI: 6.1% to 6.3%) in Spain; and 1.7% (95% CI: 1.6% to 1.8%) to 5.8% (95% CI: 5.7% to 5.9%) in France. Conclusions In this multinational study, GDM prevalence ranged from 1.3% to 15.8% depending on the algorithm and database. Nordic countries showed smaller differences in prevalence between algorithms, while the other countries showed larger variations, likely due to differences in coding practices, healthcare systems and database coverage.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Identification of gestational diabetes mellitus in European electronic healthcare databases: insights from the ConcePTION project
Date Crossref
01/10/2025
Éditeur
BMJ
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Gestational Diabetes Research and ManagementMaternal and fetal healthcarePreterm Birth and Chorioamnionitis

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.